A direct role for aberrant SPAG9 was identified in diverse human cancers such as Kaposi’s sarcoma, gastric cancer, prostate cancer, thyroid carcinoma, liver cancer, and bladder transitional cell carcinoma [26–32]. This evidence concerns the gene SPAG9 and liver cancer.